Share-based Payment Arrangement, Expense of BriaCell Therapeutics Corp. from 31 Oct 2022 to 30 Apr 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BriaCell Therapeutics Corp. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Oct 2022 to 30 Apr 2024.
  • BriaCell Therapeutics Corp. Share-based Payment Arrangement, Expense for the quarter ending 30 Apr 2024 was $392,215, a 39% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $392,215 +$111,026 +39% 01 Feb 2024 30 Apr 2024 10-Q 14 Jun 2024 2024 Q3
Q4 2023 $500,155 +$233,311 +87% 01 Nov 2023 31 Jan 2024 10-Q 18 Mar 2024 2024 Q2
Q3 2023 $533,816 -$578,125 -52% 01 Aug 2023 31 Oct 2023 10-Q 14 Dec 2023 2024 Q1
Q1 2023 $281,189 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q3
Q4 2022 $266,844 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024 2024 Q2
Q3 2022 $1,111,941 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.